<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Neoral; Ciclosporin: immunosuppression" /><meta name="IX" content="Neoral; Ciclosporin: immunosuppression" /><title>Neoral®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP5633-neoral.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP5633-neoral.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP5633-neoral.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 08 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP5179-malignant-disease-and-immunosuppression.htm">8 Malignant disease and immunosuppression</a> &gt; <a href="PHP5590-drugs-affecting-the-immune-response.htm">8.2 Drugs affecting the immune response</a> &gt; <a href="PHP5614-corticosteroids-and-other-immunosuppressants.htm">8.2.2 Corticosteroids and other immunosuppressants</a> &gt; <a href="PHP5626-ciclosporin.htm">CICLOSPORIN(Cyclosporin)</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP5624-belatacept.htm" title="Previous: BELATACEPT">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP5637-sirolimus.htm" title="Next: SIROLIMUS">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a303001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cyclosporine (EENT)</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Eye, Ear, Nose, and Throat (EENT) Preparations 52:00 &gt; Anti-inflammatory Agents 52:08 &gt; EENT Anti-inflammatory Agents, Miscellaneous 52:08.92</p></div></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a384054.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cyclosporine</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Miscellaneous Therapeutic Agents 92:00 &gt; Immunosuppressive Agents 92:44</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/1882-m.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Ciclosporin</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: C &gt; Interactions of Ciclosporin</p></div></li></ul><ul><li><h3>British National Formulary (13)</h3></li><li><a href="PHP479-inflammatory-bowel-disease.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Inflammatory bowel disease</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders</p></div></li><li><a href="PHP529-ciclosporin.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">CICLOSPORIN</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders &gt; 1.5.3 Drugs affecting the immune response</p></div></li><li><a href="PHP5614-corticosteroids-and-other-immunosuppressants.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">8.2.2 Corticosteroids and other immunosuppressants</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.2 Drugs affecting the immune response</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22ciclosporin%22%22ciclosporin%22%22ciclosporin%22%22cyclosporin%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (13)</a></li></ul><ul><li><h3>BNF for Children (9)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP11193-inflammatory-bowel-disease.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Inflammatory bowel disease</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP11229-drugs-affecting-the-immune-response.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">1.5.3 Drugs affecting the immune response</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP11232-ciclosporin.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">CICLOSPORIN</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders &gt; 1.5.3 Drugs affecting the immune response</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22ciclosporin%22%22ciclosporin%22%22ciclosporin%22%22cyclosporin%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (9)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK0367.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ciclosporin</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; C</p></div></li></ul><ul><li><h3>Dietary Supplements</h3></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/c77.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Potassium</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; P</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a585014.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cyclosporine</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; C</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0003s0730.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cyclosporine</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; C</p></div></li></ul><ul><li><h3>Injectable Drugs Guide</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/c19-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ciclosporin (cyclosporine, cyclosporin)</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; C</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/1882-m.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ciclosporin</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Immunosuppressants &gt; Drug Monographs</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-C164.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cyclosporine</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; C</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E36E3E0R0D445.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Ciclosporin</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; C</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c82.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ciclosporin</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; C</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>CICLOSPORIN<span class="cAB"><strong>(Cyclosporin)</strong></span></h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int499-ciclosporin.htm">Ciclosporin</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT"><a title="target-block: CICLOSPORIN NOTES " href="PHP5614-corticosteroids-and-other-immunosuppressants.htm#PHP5615">see notes above</a>, and under Dose; severe acute ulcerative colitis [unlicensed indication] (section <a title="BNF:monograph: CICLOSPORIN" href="PHP529-ciclosporin.htm">1.5.3</a>); rheumatoid arthritis (<a title=" Drugs which suppress the rheumatic disease process" href="PHP6554-drugs-that-suppress-the-rheumatic-disease-process.htm">section 10.1.3</a>); atopic dermatitis and psoriasis (<a title="sub-section: Drugs affecting the immune response" href="PHP7766-drugs-affecting-the-immune-response.htm">section 13.5.3</a>)</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">monitor kidney function—dose dependent increase in serum creatinine and urea during first few weeks may necessitate dose reduction in transplant patients (exclude rejection if kidney transplant) or discontinuation in non-transplant patients; monitor liver function (see Hepatic Impairment below); monitor blood pressure—discontinue if hypertension develops that cannot be controlled by antihypertensives; hyperuricaemia; monitor serum potassium especially in renal dysfunction (risk of hyperkalaemia); monitor serum magnesium; measure blood lipids before treatment and after the first month of treatment; use with tacrolimus specifically contra-indicated; for patients other than transplant recipients, preferably avoid other immunosuppressants (increased risk of infection and malignancies, including lymphoma and skin cancer); avoid excessive exposure to UV light, including sunlight; <strong>interactions: </strong>Appendix 1 (ciclosporin)</p></div><div class="cG"><div class="cE"><h3 class="cT">Additional cautions in nephrotic syndrome</h3> <p class="cT"><strong><em>Contra-indicated</em> </strong> in uncontrolled hypertension, uncontrolled infections, and malignancy; in long-term management, perform renal biopsies at yearly intervals</p></div></div><div class="cG"><div class="cE"><h3 class="cT">Additional cautions</h3> <p class="cT">Atopic Dermatitis and Psoriasis, <a title="13.5.3 Drugs affecting the immune response" href="PHP7766-drugs-affecting-the-immune-response.htm">section 13.5.3</a>; Rheumatoid Arthritis, <a title="10.1.3 Drugs that suppress the rheumatic disease process" href="PHP6554-drugs-that-suppress-the-rheumatic-disease-process.htm">section 10.1.3</a></p></div> </div></div><div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">dosage adjustment based on bilirubin and liver enzymes may be needed</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">dose as in normal renal function but see Cautions above; in nephrotic syndrome reduce dose by 25–50% if serum creatinine more than 30% above baseline on more than one measurement; in patients with nephrotic syndrome and renal impairment initially 2.5 mg/kg daily</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">crosses placenta; see <a title="BNF:target-block: pregnancy immunosuppressant" href="PHP5591-immunosuppressant-therapy.htm#PHP5593">Immunosuppressant Therapy</a></p></div></div><div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">present in milk—manufacturer advises avoid</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">anorexia, nausea, vomiting, abdominal pain, diarrhoea, gingival hyperplasia, hepatic dysfunction, hypertension, tremor, headache, paraesthesia, fatigue, renal dysfunction (renal structural changes on long-term administration, see also under Cautions), hyperuricaemia, hyperkalaemia, hypomagnesaemia, hyperlipidaemia, hypercholesterolaemia, muscle cramps, myalgia, hypertrichosis; <em>less commonly</em> oedema, weight gain, signs of encephalopathy, anaemia, thrombocytopenia; <em>rarely</em> pancreatitis, motor polyneuropathy, menstrual disturbances, gynaecomastia, microangiopathic haemolytic anaemia, haemolytic uraemic syndrome, hyperglycaemia, muscle weakness, myopathy, visual disturbances secondary to benign intracranial hypertension (discontinue); <em>also reported with infusion</em> anaphylaxis</p></div></div><div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p>Organ transplantation, used alone, <span class="cP">adult</span> and <span class="cP">child</span> over 3 months 10–15 mg/kg <span class="cK">by mouth</span> 4–12 hours before transplantation followed by 10–15 mg/kg daily for 1–2 weeks postoperatively then reduced gradually to 2–6 mg/kg daily for maintenance (dose should be adjusted according to blood-ciclosporin concentration and renal function); dose lower if given concomitantly with other immunosuppressant therapy (e.g. corticosteroids); if necessary one-third corresponding oral dose can be given <span class="cK">by intravenous infusion</span> over 2–6 hours</p></li><li><p>Bone-marrow transplantation, prevention and treatment of graft-versus-host disease, <span class="cP">adult</span> and <span class="cP">child</span> over 3 months 3–5 mg/kg daily <span class="cK">by intravenous infusion</span> over 2–6 hours from day before transplantation to 2 weeks postoperatively (or 12.5–15 mg/kg daily <span class="cK">by mouth</span> ) then 12.5 mg/kg daily <span class="cK">by mouth</span> for 3–6 months then tailed off (may take up to a year after transplantation)</p></li><li><p>Nephrotic syndrome, <span class="cK">by mouth</span>, 5 mg/kg daily in 2 divided doses; <span class="cP">child</span> 6 mg/kg daily in 2 divided doses; maintenance treatment reduce to lowest effective dose according to proteinuria and serum creatinine measurements; discontinue after 3 months if no improvement in glomerulonephritis or glomerulosclerosis (after 6 months in membranous glomerulonephritis)</p></li></ul><div class="cI"><h3 class="cT">Important</h3><p>Patients should be stabilised on a particular brand of oral ciclosporin because switching between formulations without close monitoring may lead to clinically important changes in blood-ciclosporin concentration. Prescribing and dispensing of ciclosporin should be by brand name to avoid inadvertent switching. If it is necessary to switch a patient to a different brand of ciclosporin, the patient should be monitored closely for changes in blood-ciclosporin concentration, serum creatinine, blood pressure, and transplant function.</p></div></div></div></div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="PHP5630-capimune.htm#PHP5630-capimune" title="Capimune®">Capimune®</a></li><li><a href="PHP5631-capsorin.htm#PHP5631-capsorin" title="Capsorin®">Capsorin®</a></li><li><a href="PHP5632-deximune.htm#PHP5632-deximune" title="Deximune®">Deximune®</a></li></ul><div id="PHP5633-neoral" style="margin: 0 0 0 20px;"><h1 class="title">Neoral® <span>(<a href="PHP10005-index-of-manufacturers.htm#PHP10261">Novartis</a>)</span><span> <img src="images/pom_l.png" alt="Prescription only medicine" /></span></h1><div class="cU"><p><strong>Capsules</strong>, ciclosporin 10 mg (yellow/white), net price 60-cap pack = £18.48; 25 mg (blue/grey), 30-cap pack = £18.59; 50 mg (yellow/white), 30-cap pack = £36.41; 100 mg (blue/grey), 30-cap pack = £69.11. Counselling, administration</p><p class="cR"><span class="cAD">Excipients </span>include propylene glycol (see <a title="BNF:target-block: Excipients" href="PHP60-general-guidance.htm#PHP64">Excipients</a>)</p><div class="cG"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">Contains ethanol</p></div></div></div><div class="cU"><p><strong>Oral solution</strong>, yellow, sugar-free, ciclosporin 100 mg/mL, net price 50 mL = £103.55. Counselling, administration</p><p class="cR"><span class="cAD">Excipients </span>include propylene glycol (see <a title="BNF:target-block: Excipients" href="PHP60-general-guidance.htm#PHP64">Excipients</a>)</p><div class="cG"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">Contains ethanol</p></div></div><div class="cG"><div class="cE"><h3 class="cT">Counselling</h3> <p class="cT">Total daily dose should be taken in 2 divided doses</p></div><p>Mix solution with orange juice (or squash) or apple juice (to improve taste) or with water immediately before taking (and rinse with more to ensure total dose). Do not mix with grapefruit juice. Keep medicine measure away from other liquids (including water)</p></div></div></div><ul class="jT"><li><a href="PHP5634-sandimmun.htm#PHP5634-sandimmun" title="Sandimmun®">Sandimmun®</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP5624-belatacept.htm">Previous: BELATACEPT</a> | <a class="top" href="PHP5633-neoral.htm#">Top</a> | <a accesskey="]" href="PHP5637-sirolimus.htm">Next: SIROLIMUS</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>